Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.8102 | 34 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.79742 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.80116 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.76556 | 36 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.75777 | 35 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.90176 | 36 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.78973 | 32 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.77974 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.77666 | 35 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.78598 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.78092 | 35 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.78399 | 36 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.78856 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78891 | 35 |